Haupenthal J - Search Results

1

Synthesis of some novel androstanes as potential aromatase inhibitors.

Yadav MR, Sabale PM, Giridhar R, Zimmer C, Haupenthal J, Hartmann RW. Yadav MR, et al. Among authors: haupenthal j. Steroids. 2011 Apr;76(5):464-70. doi: 10.1016/j.steroids.2010.12.013. Epub 2011 Jan 6. Steroids. 2011. PMID: 21215765

2

Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer.

Hu Q, Jagusch C, Hille UE, Haupenthal J, Hartmann RW. Hu Q, et al. Among authors: haupenthal j. J Med Chem. 2010 Aug 12;53(15):5749-58. doi: 10.1021/jm100317b. J Med Chem. 2010. PMID: 20684610

3

Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.

Aggarwal S, Thareja S, Bhardwaj TR, Haupenthal J, Hartmann RW, Kumar M. Aggarwal S, et al. Among authors: haupenthal j. Eur J Med Chem. 2012 Aug;54:728-39. doi: 10.1016/j.ejmech.2012.06.026. Epub 2012 Jun 21. Eur J Med Chem. 2012. PMID: 22776417

4

A detective story in drug discovery: elucidation of a screening artifact reveals polymeric carboxylic acids as potent inhibitors of RNA polymerase.

Zhu W, Groh M, Haupenthal J, Hartmann RW. Zhu W, et al. Among authors: haupenthal j. Chemistry. 2013 Jun 24;19(26):8397-400. doi: 10.1002/chem.201301289. Epub 2013 May 16. Chemistry. 2013. PMID: 23681768

5

Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.

Sahner JH, Groh M, Negri M, Haupenthal J, Hartmann RW. Sahner JH, et al. Among authors: haupenthal j. Eur J Med Chem. 2013 Jul;65:223-31. doi: 10.1016/j.ejmech.2013.04.060. Epub 2013 May 7. Eur J Med Chem. 2013. PMID: 23711833

6

Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.

Hinsberger S, Hüsecken K, Groh M, Negri M, Haupenthal J, Hartmann RW. Hinsberger S, et al. Among authors: haupenthal j. J Med Chem. 2013 Nov 14;56(21):8332-8. doi: 10.1021/jm400485e. Epub 2013 Oct 31. J Med Chem. 2013. PMID: 24112046

7

Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections.

Hinsberger S, de Jong JC, Groh M, Haupenthal J, Hartmann RW. Hinsberger S, et al. Among authors: haupenthal j. Eur J Med Chem. 2014 Apr 9;76:343-51. doi: 10.1016/j.ejmech.2014.02.014. Epub 2014 Feb 11. Eur J Med Chem. 2014. PMID: 24589489

8

New insights into the bacterial RNA polymerase inhibitor CBR703 as a starting point for optimization as an anti-infective agent.

Zhu W, Haupenthal J, Groh M, Fountain M, Hartmann RW. Zhu W, et al. Among authors: haupenthal j. Antimicrob Agents Chemother. 2014 Jul;58(7):4242-5. doi: 10.1128/AAC.02600-14. Epub 2014 May 12. Antimicrob Agents Chemother. 2014. PMID: 24820077 Free PMC article.

9

Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases.

Hille UE, Zimmer C, Haupenthal J, Hartmann RW. Hille UE, et al. Among authors: haupenthal j. ACS Med Chem Lett. 2011 Jun 3;2(8):559-64. doi: 10.1021/ml100283h. eCollection 2011 Aug 11. ACS Med Chem Lett. 2011. PMID: 24900349 Free PMC article.

10

Binding mode characterization of novel RNA polymerase inhibitors using a combined biochemical and NMR approach.

Fruth M, Plaza A, Hinsberger S, Sahner JH, Haupenthal J, Bischoff M, Jansen R, Müller R, Hartmann RW. Fruth M, et al. Among authors: haupenthal j. ACS Chem Biol. 2014 Nov 21;9(11):2656-63. doi: 10.1021/cb5005433. Epub 2014 Sep 26. ACS Chem Biol. 2014. PMID: 25207839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters